CA
HRTX icon

Cliff Asness’s Heron Therapeutics HRTX Stock Holding History

Cliff Asness’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Buy
1,553,857
+912,270
+142% +$731K ﹤0.01% 3245
2026
Q1 		$513K Buy
641,587
+265,287
+70% +$307K ﹤0.01% 3107
2025
Q4 		$489K Sell
376,300
-1,560,389
-81% -$1.93M ﹤0.01% 2925
2025
Q3 		$2.44M Buy
1,936,689
+1,874,940
+3,036% +$2.97M ﹤0.01% 1864
2025
Q2 		$128K Buy
61,749
+34,440
+126% +$70.3K ﹤0.01% 3138
2025
Q1 		$60.1K Sell
27,309
-187,648
-87% -$364K ﹤0.01% 3072
2024
Q4 		$329K Sell
214,957
-685,150
-76% -$1.11M ﹤0.01% 2458
2024
Q3 		$1.79M Buy
900,107
+292,972
+48% +$700K ﹤0.01% 1559
2024
Q2 		$2.12M Buy
607,135
+568,238
+1,461% +$1.75M ﹤0.01% 1427
2024
Q1 		$108K Buy
38,897
+2,042
+6% +$5.13K ﹤0.01% 2331
2023
Q4 		$62.7K Sell
36,855
-85,912
-70% -$94.6K ﹤0.01% 2301
2023
Q3 		$126K Sell
122,767
-25,184
-17% -$35.8K ﹤0.01% 2199
2023
Q2 		$172K Buy
147,951
+6,874
+5% +$12.3K ﹤0.01% 2100
2023
Q1 		$213K Buy
141,077
+89,717
+175% +$225K ﹤0.01% 2036
2022
Q4 		$128K Sell
51,360
-1,908
-4% -$6.15K ﹤0.01% 2122
2022
Q3 		$225K Buy
+53,268
New +$208K ﹤0.01% 2018
2019
Q2 		– Sell
-13,202
Closed -$323K – 2124
2019
Q1 		$323K Buy
+13,202
New +$346K ﹤0.01% 1948
2014
Q3 		– Sell
-75,000
Closed -$924K – 2548
2014
Q2 		$924K Buy
+75,000
New +$896K ﹤0.01% 1690

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Cliff Asness's HRTX Position: Q2 2026 in Review

Cliff Asness increased its Heron Therapeutics (HRTX) stake by 142% in Q2 2026, buying an estimated $731K and bringing the position to 1,553,857 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

Cliff Asness first reported a position in HRTX in Q2 2014 and has held it in 18 quarters since. The position peaked at $2.44M in Q3 2025. 161 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Cliff Asness held 1,553,857 shares of Heron Therapeutics worth $663K as of Q2 2026.
  • Cliff Asness bought 912,270 Heron Therapeutics shares in Q2 2026, an estimated $731K.
  • Heron Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3245 holding.
  • Cliff Asness first reported a position in Heron Therapeutics in Q2 2014 and has held it in 18 quarters since.
  • Cliff Asness's Heron Therapeutics position peaked at $2.44M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.